Sun Pharmaceutical Industries, India’s largest drug maker by value, is planning to raise Rs 12000 crore through qualified institutional placement (QIP) route. In this regard, the company is seeking shareholders’ approval at its 27th annual general meeting to be held by the end of September.
Real Time News & Trading Trends Keep Liking #EpicResearch
Facebook – Twitter – YouTube – Pinterest –Linkedin - Google+
For more information ✆ – 0731-6642300 or Visit http://ift.tt/1k8NnLH
0 comments:
Post a Comment